This site is for US healthcare professionals only.
INDICATION
LUTATHERA® (lutetium Lu 177 dotatate) injection is indicated for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut and hindgut neuroendocrine tumors in adults.
